HFHitoshi Fujiwara

Hitoshi Fujiwara

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hitoshi Fujiwara has a total of 177 co-authors. Here are the top co-authors by number of shared publications:

  • Atsushi Shiozaki

    Department of Surgery, Division of Digestive Surgery, Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto Japan

    25 shared publications
  • Eigo Otsuji

    Division of Digestive Surgery, Department of Surgery Kyoto Prefectural University of Medicine Kamigyo‐ku Kyoto Japan

    19 shared publications
  • Hirotaka Konishi

    Division of Digestive Surgery, Department of Surgery Kyoto Prefectural University of Medicine Kyoto Japan

    17 shared publications
  • Atsushi Shiozaki

    Division of Digestive Surgery, Department of Surgery Kyoto Prefectural University of Medicine Kamigyo‐ku Kyoto Japan

    15 shared publications
  • Kazuma Okamoto

    Division of Digestive Surgery, Department of Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan

    14 shared publications
  • Yoshiaki Kuriu

    Division of Digestive Surgery, Department of Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan

    12 shared publications

Latest Publications

  • Open Access

    A Totally Laparoscopic Transhiatal Approach for Esophageal Cancer During Mediastinoscopic Esophagectomy

    byĀ Hirotaka Konishi, Shutaro Sumiyoshi, Hiroyuki Inoue, Keiji Nishibeppu, Toshiyuki Kosuga, Yusuke Yamamoto, Ryo Morimura, Hitoshi Fujiwara, Atsushi Shiozaki

    Background: Mediastinoscopic esophagectomy is a minimally invasive approach that avoids thoracotomy and single-lung ventilation. We previously performed this procedure using hand-assisted laparoscopic surgery (HALS) and recently established a totally laparoscopic transhiatal approach. This retrospective, non-randomized study reported laparoscopic technique and compared the feasibility and surgical outcomes of these approaches. Methods: We retrospectively reviewed 262 patients who underwent radical mediastinoscopic esophagectomy using left cervical and transhiatal approaches at the Kyoto Prefectural University of Medicine between January 2020 and June 2026. HALS was performed in 202 patients and laparoscopy in 60 patients. Surgical procedures and perioperative outcomes were compared between the groups. Results: Blood loss and total operative time did not differ significantly between the groups, although the transhiatal procedure tended to require a longer operative time with laparoscopy (p = 0.09). The approach used for middle mediastinal lymphadenectomy was similar between the two groups (43% vs. 35%, p = 0.28), and the overall number of dissected lymph nodes, excluding the upper mediastinal and cervical nodes, was comparable. However, significantly more abdominal lymph nodes were dissected with laparoscopy than with HALS (17.9 vs. 15.7, p = 0.04). Laparoscopic gastric mobilization and lymph node dissection were safely performed, with no significant differences in the rate of postoperative complications or curability. Conclusions: The totally laparoscopic transhiatal technique is a feasible and safe approach for mediastinoscopic esophagectomy, with surgical outcomes comparable to those of HALS and not inferior abdominal lymph node dissection. It may be particularly advantageous for cases requiring meticulous abdominal lymphadenectomy.

  • Mediastinoscopic Esophagectomy

    byĀ Hitoshi Fujiwara, Hirotaka Konishi, Atsushi Shiozaki

  • Open Access

    Endoscopic Features of Background Gastritis Associated With Remnant Gastric Cancer: A Multicenter Retrospective Study

    byĀ Takuma Ohashi, Takeshi Kubota, Hayato Fukui, Osamu Dohi, Shuhei Komatsu, Yasuhiro Shioaki, Yasuhito Izumiya, Tetsuro Yamashita, Sachie Tanaka, Soujin Sai, et al.

    Ohashi T, et al. J Gastric Cancer. 2026 Apr;26(2):232-246. https://doi.org/10.5230/jgc.2026.26.e15


  • Open Access

    Minimally Invasive Esophagectomy for Esophageal Cancer: Current Evidence and Future Perspectives

    byĀ Hirotaka Konishi, Hiroyuki Inoue, Hitoshi Fujiwara, Atsushi Shiozaki

    Aim: Esophageal cancer is a highly aggressive malignancy with regional variations in histological subtypes. Adenocarcinoma predominates in Western countries, whereas squamous cell carcinoma is more common in Asia. Despite advances in multimodal therapy, esophagectomy remains the cornerstone of curative treatment, and the development of various minimally invasive esophagectomies (MIE) has been promoted to reduce invasiveness and complications. The status of the MIE has been outlined. Methods: A comprehensive literature review was conducted using PubMed/MEDLINE to identify relevant studies on MIE published up to June 2025. The search focused on thoracoscopic, robot‐assisted, and mediastinoscopic approaches, with an emphasis on randomized trials and high‐quality comparative studies. Results: Thoracoscopic MIE, especially in the prone position, demonstrated reduced pulmonary complications and shorter recovery times than open surgery, as supported by randomized trials such as TIME, MIRO, and MONET. Robot‐assisted MIE (RAMIE) further enhances lymph node dissection and improves preservation of the recurrent laryngeal nerve, as demonstrated in trials such as REVATE and RAMIE. Mediastinoscopic esophagectomy via the transcervical and transhiatal approaches is emerging as a promising alternative for high‐risk patients, offering favorable perioperative outcomes with reduced pulmonary complications. Further evaluation is required to determine the efficacy of lymph node dissection and the risk of recurrent laryngeal nerve damage. Conclusion: MIE, including the thoracoscopic, robot‐assisted, and mediastinoscopic approaches, is evolving into an effective and less invasive alternative to open surgery. Future research should focus on conducting standardized, multicenter trials to establish optimal surgical strategies based on tumor characteristics and patient‐specific factors.


  • Open Access

    Association between surgical difficulty and tumor location based on subsegments of the Glisson branches in laparoscopic liver resection

    byĀ Taisuke Imamura, Yusuke Yamamoto, Ryo Morimura, Hisashi Ikoma, Tomohiro Arita, Hirotaka Konishi, Atsushi Shiozaki, Takeshi Kubota, Hitoshi Fujiwara, Eigo Otsuji

    Background: Laparoscopic liver resection has a steep learning curve, and multiple difficulty‐scoring systems have been proposed to support safe implementation. Though the IWATE scoring system is widely used, the rationale for its tumor location score is unclear. The objective of our study was to establish a more accurate definition of tumor location based on subsegments of the Glisson branches.Methods: We included 176 patients who underwent laparoscopic liver resection between January 2017 and February 2024, excluding those who underwent multiple or concomitant resections of other organs. Tumor location was defined by the most proximal subsegment of the Glisson branches (1sp, Spiegel; 1pc, para‐caval; 1cp, caudate process; 3a, apical; 3b, basal; 4a; 4b; 5v, ventral; 5d, dorsal; 6v; 6d; 6 L, lateral; 7v; 7d; 8v; 8d).Results: Within each segment, comparing operative time between subsegments showed significant differences, except for S1 (3a vs. 3b, p = 0.011; 4a vs. 4b, p = 0.001; 5v vs. 5d, p = 0.012; 6v vs. 6d vs. 6 L, p = 0.007; 7v vs. 7d, p = 0.003; 8v vs. 8d, p = 0.030). Blood loss significantly differed except for S1 (3a vs. 3b, p = 0.018; 4a vs. 4b, p = 0.002; 5v vs. 5d, p = 0.016; 6v vs. 6d vs. 6 L, p = 0.011; 7v vs. 7d, p = 0.013; 8v vs. 8d, p < 0.001). The incidence of postoperative complications did not differ significantly; however, hospital stay was significantly different only in S4 (4a vs. 4b, p = 0.049).Conclusions: There are significant differences in the difficulty of laparoscopic liver resection among subsegments. More detailed scoring based on subsegments may improve accuracy, and we propose a new scoring system.


  • Open Access

    Utility for Postoperative Respiratory Function of Transmediastinal Esophagectomy for Esophageal Carcinoma

    byĀ Shutaro Sumiyoshi, Atsushi Shiozaki, Hitoshi Fujiwara, Hirotaka Konishi, Hiroyuki Inoue, Kazuya Takabatake, Keiji Nishibeppu, Jun Kiuchi, Taisuke Imamura, Kenji Nanishi, et al.

    Background/Aim: Esophagectomy for esophageal carcinoma (EC) is known to lead to deterioration of respiratory function (RF) due to thoracotomy and mediastinal lymph node dissection. This study aimed to evaluate the impact of transmediastinal esophagectomy (TME) on pulmonary function. Patients and Methods: We retrospectively analyzed the data of 102 patients with EC who underwent transthoracic esophagectomy (TTE) or TME and underwent RF tests within three months postoperatively at Kyoto Prefectural University of Medicine between 2014 and 2022. Perioperative pulmonary functions were evaluated based on vital capacity (VC) and forced expiratory volume in one second (FEV1.0). Results: Among 102 patients undergoing esophagectomy, 12 (11.8%) patients were included in the TTE group, and the remaining 90 (88.2%) patients were included in the TME group. Neoadjuvant treatments were significantly more common in the TTE group (p=0.011), with more advanced tumor stages (p=0.017). The TME group had significantly lower estimated blood loss (p=0.015). RF after esophagectomy showed a decrease in VC, and VC of predicted (%VC). The decrease rate in VC, %VC, and FEV1.0 was significantly greater in the TTE group than in the TME group. Conclusion: TME is a surgical procedure with a less severe postoperative decline in RF than TTE.

  • Open Access

    Predictors of the difficulty of transcervical subcarinal lymph node dissection for esophageal cancer

    byĀ Hirotaka Furuke, Hirotaka Konishi, Hitoshi Fujiwara, Atsushi Shiozaki, Takuma Ohashi, Hiroki Shimizu, Tomohiro Arita, Yusuke Yamamoto, Ryo Morimura, Yoshiaki Kuriu, et al.

    Background: Transmediastinal radical esophagectomy (TME) is a new minimally invasive approach without thoracotomy. However, the transcervical dissection of subcarinal lymph nodes (SCLN) is challenging. The shape or narrowness of the mediastinal space, particularly around the aortic arch to the tracheal bifurcation, may increase the difficulty of this procedure. The present study aimed to clarify predictors of the difficulty of transcervical SCLN dissection. Methods: Patients who underwent TME between 2016 and 2019 were included (n = 126). Four indicators, the cervical angle, carina distance, aorta distance, and sternum distance, were defined as indicators of mediastinal narrowness by 3D-CT. The relationships between the difficulty of transcervical SCLN dissection and clinicopathological features, including the above indicators, were investigated. Results: In a univariate analysis, the cervical angle (p = 0.023), aorta distance (p = 0.002), and middle thoracic tumor (p = 0.040) correlated with difficulty. The median cervical angle and aorta distance were 15° and 33 mm in difficult cases and 19° and 43 mm in easy cases, respectively. In a multivariate analysis, the short aorta distance (odds ratio: 7.96, p = 0.002) and middle thoracic tumor (odds ratio: 3.35, p = 0.042) were independent predictive factors. Conclusions: The cervical angle, aorta distance, and middle thoracic tumor may predict the difficulty of transcervical SCLN dissection. In difficult cases, a transhiatal approach should be combined for complete SCLN dissection.


  • Open Access

    Absolute lymphocyte count and C‑reactive protein‑albumin ratio can predict prognosis and adverse events in patients with recurrent esophageal cancer treated with nivolumab therapy

    byĀ Hiroyuki Inoue, Atsushi Shiozaki, Hitoshi Fujiwara, Hirotaka Konishi, Jun Kiuchi, Takuma Ohashi, Hiroki Shimizu, Tomohiro Arita, Yusuke Yamamoto, Ryo Morimura, et al.

    Predicting the prognosis and adverse events (AEs) of nivolumab therapy for recurrent esophageal cancer is very important. The present study investigated whether a simple blood biochemical examination could be used to predict prognosis and AEs following nivolumab treatment for relapse of esophageal cancer. A total of 41 patients who received nivolumab treatment for recurrent esophageal cancer after esophagectomy were analyzed. The absolute lymphocyte count (ALC), neutrophil‑lymphocyte ratio (NLR), platelet‑lymphocyte ratio (PLR), monocyte‑lymphocyte ratio (MLR) and C‑reactive protein‑albumin ratio (CAR) were assessed at the time of nivolumab induction as indices that can be calculated by blood biochemical examinations alone. Median values were 1,015 for ALC, 3.401 for NLR, 242.6 for PLR, 0.458 for MLR and 0.119 for CAR, and patients were divided into two groups according to values. A high ALC, low NLR, low PLR, low MLR and low CAR were associated with a better response to nivolumab. In addition, patients with the aforementioned indices, with the exception of low PLR, or better response were more likely to develop AEs in univariate analysis. In multivariate analysis, a high ALC [odds ratio (OR): 4.857, P=0.043] and low CAR (OR: 9.099, P=0.004) were identified as independent risk factors for AEs. Survival analysis revealed that overall survival and progression‑free survival (PFS) rates after nivolumab treatment differed significantly between the high and low groups of ALC, NLR, PLR, MLR and CAR. The multivariate analysis identified a low ALC [hazard ratio (HR): 3.710, P=0.003] and high CAR (HR: 2.953, P=0.007) as independent poor prognostic factors of PFS. In conclusion, ALC and CAR have potential as biomarkers for outcomes of recurrent esophageal cancer following nivolumab treatment.


  • Minimally Invasive Cervical Esophagectomy (MICE), radical esophagectomy and 3-field lymphadenectomy without thoracic access.

    byĀ Bastiaan Klarenbeek, Atsushi Shiozaki, Hitoshi Fujiwara, Camiel Rosman

  • Open Access

    Persistent Postgastrectomy Hypoglycemia Unawareness in Patients With Gastric Cancer Unveiled by a Prospective Study

    byĀ Takeshi Kubota, Masayuki Yubakami, Emi Ushigome, Takuma Ohashi, Katsutoshi Shoda, Hirotaka Konishi, Atsushi Shiozaki, Hitoshi Fujiwara, Kazuma Okamoto, Michiaki Fukui, et al.

    Objective: Late dumping syndrome is a common postgastrectomy complication characterized by reactive hypoglycemia. This study aimed to explore the glycemic trend in patients who underwent gastrectomy for gastric cancer and clarify its changes over time in association with postgastrectomy symptoms. Summary Background Data: Changes over time in glycemic trend in association with postgastrectomy symptoms have not been evaluated. Methods: We conducted a prospective study of 71 patients who underwent curative gastrectomy for gastric cancer between November 2017 and April 2020. The patients underwent continuous glucose monitoring twice—at 1- and 12-month postgastrectomy—and were assessed using the Post-Gastrectomy Syndrome Assessment Scale 37-item questionnaire (PGSAS-37) at 1-, 6-, and 12-month postgastrectomy. Results: Our results revealed that hypoglycemia (<70 mg/dL), especially nocturnal hypoglycemia (00:00āˆ’06:00), frequently occurred even at 12-month postgastrectomy. Hypoglycemia improved in total gastrectomy patients but remained unchanged in distal gastrectomy patients, which was still high in both groups at 12-month postgastrectomy. Glycemic variability (SD of the glycemic trend) was exacerbated in both gastrectomy groups. However, the PGSAS-37 symptom scores remained unchanged, and the living status and quality of life tended to improve. Hypoglycemia unawareness, including postprandial hypoglycemia without symptoms and nocturnal hypoglycemia, was evident even 12-month postgastrectomy. Conclusions: Persistent postgastrectomy hypoglycemia unawareness, including late dumping syndrome without symptoms and nocturnal hypoglycemia, should be recognized as an important issue in postgastrectomy syndrome. Therefore, meticulous long-term evaluation for glycemic trends and care of patients is required.